Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency


The Myc oncogene regulates the expression of several components of the protein synthetic machinery, including ribosomal proteins, initiation factors of translation, RNA polymerase III and ribosomal DNA1,2. Whether and how increasing the cellular protein synthesis capacity affects the multistep process leading to cancer remains to be addressed. Here we use ribosomal protein heterozygote mice as a genetic tool to restore increased protein synthesis in Eμ-Myc/+ transgenic mice to normal levels, and show that the oncogenic potential of Myc in this context is suppressed. Our findings demonstrate that the ability of Myc to increase protein synthesis directly augments cell size and is sufficient to accelerate cell cycle progression independently of known cell cycle targets transcriptionally regulated by Myc. In addition, when protein synthesis is restored to normal levels, Myc-overexpressing precancerous cells are more efficiently eliminated by programmed cell death. Our findings reveal a new mechanism that links increases in general protein synthesis rates downstream of an oncogenic signal to a specific molecular impairment in the modality of translation initiation used to regulate the expression of selective messenger RNAs. We show that an aberrant increase in cap-dependent translation downstream of Myc hyperactivation specifically impairs the translational switch to internal ribosomal entry site (IRES)-dependent translation that is required for accurate mitotic progression. Failure of this translational switch results in reduced mitotic-specific expression of the endogenous IRES-dependent form of Cdk11 (also known as Cdc2l and PITSLRE)3,4,5, which leads to cytokinesis defects and is associated with increased centrosome numbers and genome instability in Eμ-Myc/+ mice. When accurate translational control is re-established in Eμ-Myc/+ mice, genome instability is suppressed. Our findings demonstrate how perturbations in translational control provide a highly specific outcome for gene expression, genome stability and cancer initiation that have important implications for understanding the molecular mechanism of cancer formation at the post-genomic level.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout

Figure 1: Myc-induced increases in protein synthesis regulates B-lymphocyte size, division and apoptosis before lymphomagenesis.
Figure 2: The ability of Myc to augment protein synthesis is necessary for its oncogenic potential.
Figure 3: Myc hyperactivation impairs the translational switch from cap- to IRES-dependent translation control during mitosis and blocks mitotic translation of the Cdk11 kinase.
Figure 4: Aberrant translation control downstream of Myc activation underlies cytokinesis defects and genome instability.


  1. Gomez-Roman, N. et al. Activation by c-Myc of transcription by RNA polymerases I, II and III. Biochem. Soc. Symp. 73, 141–154 (2006)

    Article  CAS  Google Scholar 

  2. Ruggero, D. & Pandolfi, P. P. Does the ribosome translate cancer? Nature Rev. Cancer 3, 179–192 (2003)

    Article  CAS  Google Scholar 

  3. Cornelis, S. et al. Identification and characterization of a novel cell cycle-regulated internal ribosome entry site. Mol. Cell 5, 597–605 (2000)

    Article  CAS  Google Scholar 

  4. Petretti, C. et al. The PITSLRE/CDK11p58 protein kinase promotes centrosome maturation and bipolar spindle formation. EMBO Rep. 7, 418–424 (2006)

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Wilker, E. W. et al. 14-3-3σ controls mitotic translation to facilitate cytokinesis. Nature 446, 329–332 (2007)

    Article  ADS  CAS  Google Scholar 

  6. Boxer, L. M. & Dang, C. V. Translocations involving c-myc and c-myc function. Oncogene 20, 5595–5610 (2001)

    Article  CAS  Google Scholar 

  7. Pelengaris, S., Khan, M. & Evan, G. c-MYC: more than just a matter of life and death. Nature Rev. Cancer 2, 764–776 (2002)

    Article  CAS  Google Scholar 

  8. Grewal, S. S., Li, L., Orian, A., Eisenman, R. N. & Edgar, B. A. Myc-dependent regulation of ribosomal RNA synthesis during Drosophila development. Nature Cell Biol. 7, 295–302 (2005)

    Article  CAS  Google Scholar 

  9. Johnston, L. A., Prober, D. A., Edgar, B. A., Eisenman, R. N. & Gallant, P. Drosophila myc regulates cellular growth during development. Cell 98, 779–790 (1999)

    Article  CAS  Google Scholar 

  10. Moreno, E. & Basler, K. dMyc transforms cells into super-competitors. Cell 117, 117–129 (2004)

    Article  CAS  Google Scholar 

  11. de la Cova, C., Abril, M., Bellosta, P., Gallant, P. & Johnston, L. A. Drosophila myc regulates organ size by inducing cell competition. Cell 117, 107–116 (2004)

    Article  CAS  Google Scholar 

  12. Oliver, E. R., Saunders, T. L., Tarle, S. A. & Glaser, T. Ribosomal protein L24 defect in belly spot and tail (Bst), a mouse Minute . Development 131, 3907–3920 (2004)

    Article  CAS  Google Scholar 

  13. Harris, A. W. et al. The Eμ-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells. J. Exp. Med. 167, 353–371 (1988)

    Article  CAS  Google Scholar 

  14. Iritani, B. M. & Eisenman, R. N. c-Myc enhances protein synthesis and cell size during B lymphocyte development. Proc. Natl Acad. Sci. USA 96, 13180–13185 (1999)

    Article  ADS  CAS  Google Scholar 

  15. Thomas, G. An encore for ribosome biogenesis in the control of cell proliferation. Nature Cell Biol. 2, E71–E72 (2000)

    Article  CAS  Google Scholar 

  16. Yang, W. et al. Repression of transcription of the p27Kip1 cyclin-dependent kinase inhibitor gene by c-Myc. Oncogene 20, 1688–1702 (2001)

    Article  CAS  Google Scholar 

  17. Wu, S. et al. Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter. Oncogene 22, 351–360 (2003)

    Article  CAS  Google Scholar 

  18. Bouchard, C. et al. Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27. EMBO J. 18, 5321–5333 (1999)

    Article  CAS  Google Scholar 

  19. Pyronnet, S. & Sonenberg, N. Cell-cycle-dependent translational control. Curr. Opin. Genet. Dev. 11, 13–18 (2001)

    Article  CAS  Google Scholar 

  20. Hellen, C. U. & Sarnow, P. Internal ribosome entry sites in eukaryotic mRNAmolecules. Genes Dev. 15, 1593–1612 (2001)

    Article  CAS  Google Scholar 

  21. Dave, B. J. et al. Deletion of cell division cycle 2-like 1 gene locus on 1p36 in non-Hodgkin lymphoma. Cancer Genet. Cytogenet. 108, 120–126 (1999)

    Article  CAS  Google Scholar 

  22. Nelson, M. A. et al. Abnormalities in the p34cdc2-related PITSLRE protein kinase gene complex (CDC2L) on chromosome band 1p36 in melanoma. Cancer Genet. Cytogenet. 108, 91–99 (1999)

    Article  CAS  Google Scholar 

  23. Lahti, J. M. et al. Alterations in the PITSLRE protein kinase gene complex on chromosome 1p36 in childhood neuroblastoma. Nature Genet. 7, 370–375 (1994)

    Article  CAS  Google Scholar 

  24. Chandramouli, A. et al. Haploinsufficiency of the cdc2l gene contributes to skin cancer development in mice. Carcinogenesis 28, 2028–2035 (2007)

    Article  CAS  Google Scholar 

  25. Fujiwara, T. et al. Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature 437, 1043–1047 (2005)

    Article  ADS  CAS  Google Scholar 

  26. Wade, M. & Wahl, G. M. c-Myc, genome instability, and tumorigenesis: the devil is in the details. Curr. Top. Microbiol. Immunol. 302, 169–203 (2006)

    CAS  Google Scholar 

  27. Amsterdam, A. et al. Many ribosomal protein genes are cancer genes in zebrafish. PLoS Biol. 2, e139 (2004)

    Article  Google Scholar 

  28. Ganem, N. J., Storchova, Z. & Pellman, D. Tetraploidy, aneuploidy and cancer. Curr. Opin. Genet. Dev. 17, 157–162 (2007)

    Article  CAS  Google Scholar 

  29. Svitkin, Y. V. et al. Eukaryotic translation initiation factor 4E availability controls the switch between cap-dependent and internal ribosomal entry site-mediated translation. Mol. Cell. Biol. 25, 10556–10565 (2005)

    Article  CAS  Google Scholar 

  30. Yoon, A. et al. Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita. Science 312, 902–906 (2006)

    Article  ADS  CAS  Google Scholar 

  31. Ruggero, D. L. et al. The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis. Nature Med. 10, 484–486 (2004)

    Article  CAS  Google Scholar 

  32. Lenahan, M. K. & Ozer, H. L. Induction of c-myc mediated apoptosis in SV40-transformed rat fibroblasts. Oncogene 12, 1847–1854 (1996)

    CAS  PubMed  Google Scholar 

  33. Ferguson, A. M., White, L. S., Donovan, P. J. & Piwnica-Worms, H. Normal cell cycle and checkpoint responses in mice and cells lacking Cdc25B and Cdc25C protein phosphatases. Mol. Cell Biol. 25, 2853–2860 (2005)

    Article  CAS  Google Scholar 

  34. Beretta, L., Gingras, A. C., Svitkin Y.V, M. N. & Sonenberg, N. Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. Embo J. 15, 658–664 (1996)

    Article  CAS  Google Scholar 

  35. Kallioniemi, O. P. et al. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosom. Cancer 10, 231–243 (1994)

    Article  CAS  Google Scholar 

Download references


We thank F. McCormick, G. Evan and P. O’Farrell for critically reading the manuscript; J. Testa for support and critical discussion during early stages of this work; W. Xu and R. Adamo for technical assistance; J. Copley for editing the manuscript, S. Cornelis for the Cdk11 IRES bicistronic vector. This work was supported by the NIH (D.R.) and the Sandler Foundation (M.B.).

Author Contributions M.B. and D.R. conceived the experiments. M.B. designed and M.B., A.Y., O.Z., M.C. and N.K. performed experiments and collected data. E.R. analysed the lymphoid compartment of ribosomal protein heterozygote mice. P.H.R. designed, performed and interpreted CGH experiments. M.B. and D.R. analysed the data and wrote the manuscript.

Author information

Authors and Affiliations


Corresponding authors

Correspondence to Maria Barna or Davide Ruggero.

Supplementary information

Supplementary Information

This file contains Supplementary Figures 1-7 with Legends. (PDF 6443 kb)

PowerPoint slides

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Barna, M., Pusic, A., Zollo, O. et al. Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency. Nature 456, 971–975 (2008).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing